Pregabalin augmentation to antidepressants in patients with major depressive disorder

[1]  P. Masand,et al.  Pregabalin augmentation of antidepressants in patients with accident-related posttraumatic stress disorder: an open label pilot study , 2009, International clinical psychopharmacology.

[2]  N. Lodge,et al.  Ion channels as potential targets for the treatment of depression. , 2008, Current opinion in drug discovery & development.

[3]  L. Arnold,et al.  Randomized , Double-Blinded , Placebo-Controlled onotherapy Trial of Pregabalin in Patients With Fibromyalg esley , 2008 .

[4]  P. Masand,et al.  The relationship between fibromyalgia and major depressive disorder: a comprehensive review , 2008, Current medical research and opinion.

[5]  D. Stein,et al.  Efficacy of pregabalin in depressive symptoms associated with generalized anxiety disorder: A pooled analysis of 6 studies , 2008, European Neuropsychopharmacology.

[6]  N. Gajraj.  Pregabalin: Its Pharmacology and Use in Pain Management , 2007, Anesthesia and analgesia.

[7]  Mostafa Showraki.  Pregabalin in the treatment of depression , 2007, Journal of psychopharmacology.

[8]  R. Owen.  Pregabalin: its efficacy, safety and tolerability profile in generalized anxiety. , 2007, Drugs of today.

[9]  J. Krystal,et al.  Cortical γ-Aminobutyric Acid Concentrations in Depressed Patients Receiving Cognitive Behavioral Therapy , 2006, Biological Psychiatry.

[10]  J. Krystal,et al.  Cortical gamma-aminobutyric acid concentrations in depressed patients receiving cognitive behavioral therapy. , 2006, Biological psychiatry.

[11]  M. Brodie,et al.  Pregabalin Drug Interaction Studies: Lack of Effect on the Pharmacokinetics of Carbamazepine, Phenytoin, Lamotrigine, and Valproate in Patients with Partial Epilepsy , 2005, Epilepsia.

[12]  P. Matthews,et al.  Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor. , 2004, The American journal of psychiatry.

[13]  R. Shrivastava,et al.  A Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study of Pregabalin in Patients With Generalized Anxiety Disorder , 2003, Journal of clinical psychopharmacology.

[14]  J. Krystal,et al.  Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. , 2002, The American journal of psychiatry.

[15]  G F Mason,et al.  Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments , 2002, Molecular Psychiatry.